| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Nanoparticle therapeutics: an emerging treatment modality for cancer.
|
Nat Rev Drug Discov
|
2008
|
12.72
|
|
2
|
Therapeutic nanoparticles for drug delivery in cancer.
|
Clin Cancer Res
|
2008
|
5.67
|
|
3
|
Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft model.
|
Clin Cancer Res
|
2005
|
2.43
|
|
4
|
Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy.
|
Int J Nanomedicine
|
2008
|
2.20
|
|
5
|
Application of nanotechnology in cancer therapy and imaging.
|
CA Cancer J Clin
|
2008
|
2.15
|
|
6
|
Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic study.
|
Cancer Prev Res (Phila)
|
2013
|
1.56
|
|
7
|
p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells.
|
J Clin Invest
|
2010
|
1.50
|
|
8
|
CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models.
|
Cancer Res
|
2007
|
1.38
|
|
9
|
Detection of circulating tumor cells in human peripheral blood using surface-enhanced Raman scattering nanoparticles.
|
Cancer Res
|
2011
|
1.36
|
|
10
|
HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors.
|
ACS Nano
|
2009
|
1.29
|
|
11
|
Understanding metastatic SCCHN cells from unique genotypes to phenotypes with the aid of an animal model and DNA microarray analysis.
|
Clin Exp Metastasis
|
2006
|
1.19
|
|
12
|
Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR.
|
Oncogene
|
2005
|
1.13
|
|
13
|
Detection of Cancer Metastasis Using a Novel Macroscopic Hyperspectral Method.
|
Proc SPIE Int Soc Opt Eng
|
2012
|
1.11
|
|
14
|
Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin: potential role of p53.
|
J Biol Chem
|
2010
|
1.08
|
|
15
|
New perspectives of curcumin in cancer prevention.
|
Cancer Prev Res (Phila)
|
2013
|
1.05
|
|
16
|
Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies.
|
Clin Cancer Res
|
2013
|
1.02
|
|
17
|
Elevated expression of eukaryotic translation initiation factor 4E is associated with proliferation, invasion and acquired resistance to erlotinib in lung cancer.
|
Cancer Biol Ther
|
2012
|
1.02
|
|
18
|
Advances of cancer therapy by nanotechnology.
|
Cancer Res Treat
|
2009
|
1.01
|
|
19
|
Quantum dot-based quantification revealed differences in subcellular localization of EGFR and E-cadherin between EGFR-TKI sensitive and insensitive cancer cells.
|
Nanotechnology
|
2009
|
0.99
|
|
20
|
Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth.
|
J Control Release
|
2012
|
0.99
|
|
21
|
Interaction between epidermal growth factor receptor- and cyclooxygenase 2-mediated pathways and its implications for the chemoprevention of head and neck cancer.
|
Mol Cancer Ther
|
2005
|
0.97
|
|
22
|
A Minimum Spanning Forest-Based Method for Noninvasive Cancer Detection With Hyperspectral Imaging.
|
IEEE Trans Biomed Eng
|
2015
|
0.95
|
|
23
|
Prognostic impact of Fas-associated death domain, a key component in death receptor signaling, is dependent on the presence of lymph node metastasis in head and neck squamous cell carcinoma.
|
Cancer Biol Ther
|
2013
|
0.95
|
|
24
|
Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles.
|
ACS Nano
|
2011
|
0.95
|
|
25
|
RRM2 regulates Bcl-2 in head and neck and lung cancers: a potential target for cancer therapy.
|
Clin Cancer Res
|
2013
|
0.95
|
|
26
|
A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model.
|
ACS Nano
|
2011
|
0.94
|
|
27
|
Correlation of protease-activated receptor-1 with differentiation markers in squamous cell carcinoma of the head and neck and its implication in lymph node metastasis.
|
Clin Cancer Res
|
2004
|
0.93
|
|
28
|
Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer.
|
Eur J Cancer
|
2012
|
0.91
|
|
29
|
Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinoma.
|
Cancer Prev Res (Phila)
|
2009
|
0.90
|
|
30
|
Advances in Targeting HER3 as an Anticancer Therapy.
|
Chemother Res Pract
|
2012
|
0.90
|
|
31
|
Tumor cytotoxicity of 5,6-dimethyl-1,10-phenanthroline and its corresponding gold(III) complex.
|
J Inorg Biochem
|
2011
|
0.90
|
|
32
|
Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nuclear factor-kappaB.
|
Cancer Prev Res (Phila)
|
2009
|
0.90
|
|
33
|
Targeted iron-oxide nanoparticle for photodynamic therapy and imaging of head and neck cancer.
|
ACS Nano
|
2014
|
0.89
|
|
34
|
Localization-specific LKB1 loss in head and neck squamous cell carcinoma metastasis.
|
Head Neck
|
2010
|
0.87
|
|
35
|
A dual-targeting antibody against EGFR-VEGF for lung and head and neck cancer treatment.
|
Int J Cancer
|
2011
|
0.87
|
|
36
|
Down-regulation of S100A2 in lymph node metastases of head and neck cancer.
|
Head Neck
|
2007
|
0.86
|
|
37
|
Biodistribution Study of Nanoparticle Encapsulated Photodynamic Therapy Drugs Using Multispectral Imaging.
|
Proc SPIE Int Soc Opt Eng
|
2013
|
0.82
|
|
38
|
Interruption of nuclear localization of ATBF1 during the histopathologic progression of head and neck squamous cell carcinoma.
|
Head Neck
|
2012
|
0.81
|
|
39
|
Quantum dot-based, quantitative, and multiplexed assay for tissue staining.
|
ACS Appl Mater Interfaces
|
2013
|
0.81
|
|
40
|
Sequence dependence of cell growth inhibition by EGFR-tyrosine kinase inhibitor ZD1839, docetaxel, and cisplatin in head and neck cancer.
|
Head Neck
|
2009
|
0.80
|
|
41
|
Human papillomavirus 16 oncoprotein regulates the translocation of β-catenin via the activation of epidermal growth factor receptor.
|
Cancer
|
2014
|
0.79
|
|
42
|
Mutation and Transcriptional Profiling of Formalin-Fixed Paraffin Embedded Specimens as Companion Methods to Immunohistochemistry for Determining Therapeutic Targets in Oropharyngeal Squamous Cell Carcinoma (OPSCC): A Pilot of Proof of Principle.
|
Head Neck Pathol
|
2014
|
0.78
|
|
43
|
Heat shock protein 90 (HSP90) is overexpressed in p16-negative oropharyngeal squamous cell carcinoma, and its inhibition in vitro potentiates the effects of chemoradiation.
|
Cancer Chemother Pharmacol
|
2014
|
0.78
|
|
44
|
Induction of cell cycle arrest and apoptosis by a combined treatment with 13-cis-retinoic acid, interferon-alpha2a, and alpha-tocopherol in squamous cell carcinoma of the head and neck.
|
Head Neck
|
2007
|
0.77
|
|
45
|
Combination of erlotinib and EGCG induces apoptosis of head and neck cancers through posttranscriptional regulation of Bim and Bcl-2.
|
Apoptosis
|
2015
|
0.76
|
|
46
|
Distinct growth factor-induced dynamic mass redistribution (DMR) profiles for monitoring oncogenic signaling pathways in various cancer cells.
|
J Recept Signal Transduct Res
|
2009
|
0.76
|
|
47
|
Pharmacodynamics of DT-IgG, a dual-targeting antibody against VEGF-EGFR, in tumor xenografted mice.
|
Cancer Chemother Pharmacol
|
2011
|
0.76
|
|
48
|
Antitumor properties of five-coordinate gold(III) complexes bearing substituted polypyridyl ligands.
|
J Inorg Biochem
|
2013
|
0.76
|
|
49
|
PASuite: a preprocessing algorithm suite for cellular and molecular image classification in cancer diagnosis and treatment.
|
Conf Proc IEEE Eng Med Biol Soc
|
2008
|
0.75
|